Search

everythinglearnresearchcommunity

for

Search:↓

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Stressed fibroblasts greatly increase melanin production in hair, skin, and eye cells, mainly due to a growth factor called bFGF.

Acne significantly affects both physical health and mental well-being.

Twist1 helps maintain important features of cells crucial for hair growth by working with Tcf4 and β-catenin.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

The Asian herbal mix with Houttuynia cordata, Perilla frutescens, and green tea helped grow hair in mice.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

PCOS is a major cause of infertility and requires personalized treatment.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

IGF-1, KGF, and stem cells help skin cells move and survive, potentially speeding up wound healing.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.